These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15709184

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer.
    Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Sasaki C, Rimm DL, Psyrri A.
    Clin Cancer Res; 2004 Sep 01; 10(17):5684-91. PubMed ID: 15355894
    [Abstract] [Full Text] [Related]

  • 5. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
    Lai JP, Tong CL, Hong C, Xiao JY, Tao ZD, Zhang Z, Tong WM, Betz CS.
    Laryngoscope; 2002 Feb 01; 112(2):402-8. PubMed ID: 11889405
    [Abstract] [Full Text] [Related]

  • 6. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
    Vielba R, Bilbao J, Ispizua A, Zabalza I, Alfaro J, Rezola R, Moreno E, Elorriaga J, Alonso I, Baroja A, de la Hoz C.
    Laryngoscope; 2003 Jan 01; 113(1):167-72. PubMed ID: 12514403
    [Abstract] [Full Text] [Related]

  • 7. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
    Bova RJ, Quinn DI, Nankervis JS, Cole IE, Sheridan BF, Jensen MJ, Morgan GJ, Hughes CJ, Sutherland RL.
    Clin Cancer Res; 1999 Oct 01; 5(10):2810-9. PubMed ID: 10537346
    [Abstract] [Full Text] [Related]

  • 8. An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
    Morshed K, Skomra D, Korobowicz E, Szymański M, Polz-Dacewicz M, Gołabek W.
    Acta Otolaryngol; 2007 Jul 01; 127(7):760-9. PubMed ID: 17573573
    [Abstract] [Full Text] [Related]

  • 9. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
    Tsuzuki H, Sunaga H, Ito T, Narita N, Sugimoto C, Fujieda S.
    Arch Otolaryngol Head Neck Surg; 2005 Dec 01; 131(12):1071-8. PubMed ID: 16365220
    [Abstract] [Full Text] [Related]

  • 10. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, Sanchez-Cespedes M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8486-92. PubMed ID: 15623629
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [Abstract] [Full Text] [Related]

  • 12. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.
    Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, Haffty BG.
    Arch Otolaryngol Head Neck Surg; 2001 Jul 01; 127(7):780-5. PubMed ID: 11448349
    [Abstract] [Full Text] [Related]

  • 13. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 2005 Jun 01; 11(11):4107-16. PubMed ID: 15930346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
    Suwinski R, Jaworska M, Nikiel B, Grzegorz W, Bankowska-Wozniak M, Wojciech M, Krzysztof S, Dariusz L.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):438-46. PubMed ID: 19733016
    [Abstract] [Full Text] [Related]

  • 16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E.
    Int J Clin Pract; 2008 Nov 01; 62(11):1736-43. PubMed ID: 19143860
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA, Filipits M.
    J Oral Pathol Med; 2012 Jan 01; 41(1):40-6. PubMed ID: 21883486
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A.
    Cancer Res; 1995 Mar 01; 55(5):975-8. PubMed ID: 7867006
    [Abstract] [Full Text] [Related]

  • 19. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
    Chang AR, Wu HG, Park CI, Jun YK, Kim CW.
    Head Neck; 2008 Jul 01; 30(7):852-7. PubMed ID: 18302259
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
    Tomazic A, Pegan V, Ferlan-Marolt K, Pleskovic A, Luzar B.
    Hepatogastroenterology; 2004 Jul 01; 51(60):1832-7. PubMed ID: 15532837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.